Cargando…
Myricetin as a Promising Molecule for the Treatment of Post-Ischemic Brain Neurodegeneration
The available drug therapy for post-ischemic neurodegeneration of the brain is symptomatic. This review provides an evaluation of possible dietary therapy for post-ischemic neurodegeneration with myricetin. The purpose of this review was to provide a comprehensive overview of what scientists have do...
Autores principales: | Pluta, Ryszard, Januszewski, Sławomir, Czuczwar, Stanisław J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7911478/ https://www.ncbi.nlm.nih.gov/pubmed/33498897 http://dx.doi.org/10.3390/nu13020342 |
Ejemplares similares
-
Neuroinflammation in Post-Ischemic Neurodegeneration of the Brain: Friend, Foe, or Both?
por: Pluta, Ryszard, et al.
Publicado: (2021) -
Post-Ischemic Neurodegeneration of the Hippocampus Resembling Alzheimer’s Disease Proteinopathy
por: Pluta, Ryszard, et al.
Publicado: (2021) -
The Many Faces of Post-Ischemic Tau Protein in Brain Neurodegeneration of the Alzheimer’s Disease Type
por: Pluta, Ryszard, et al.
Publicado: (2021) -
Post-Ischemic Brain Neurodegeneration in the Form of Alzheimer’s Disease Proteinopathy: Possible Therapeutic Role of Curcumin
por: Pluta, Ryszard, et al.
Publicado: (2022) -
Molecular Hydrogen Neuroprotection in Post-Ischemic Neurodegeneration in the Form of Alzheimer’s Disease Proteinopathy: Underlying Mechanisms and Potential for Clinical Implementation—Fantasy or Reality?
por: Pluta, Ryszard, et al.
Publicado: (2022)